Immunosuppressive therapy in small animals (Proceedings)
Although newer therapies are being developed in humans that allow a certain targeting specificity, immunosuppressive therapy in dogs and cats is largely based on the use chemotherapeutic drugs. Liver and hematological toxicity are major limiting factors that often can be reduced with the use of appropriate drug combinations. Therapeutic protocols are largely empirical and further pharmacokinetic, efficacy and safety information are required to better use these drugs in cats. This review focuses on current safety and efficacy data of common and newer immunosuppressive agents in feline patients.
Objectives Of The Presentation
1. To evaluate currently available agents and treatment protocols for immunosuppressive therapy in small animals, with particular emphasis on cats.Relevant Therapeutic Points
1. The use of immunosuppressive drugs is often chronic and toxicity is the major limiting factor of therapy.